GEORG FERTIG,THOMAS FRIESS,CHRISTIAN KLEIN,PABLO UMANA
申请号：
US14305996
公开号：
US20160000912A1
申请日:
2014.06.16
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a proteasome inhibitor for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type II anti-CD20 antibody and a proteasome inhibitor. Another aspect of the invention is a kit comprising a type II anti-CD20 antibody and a proteasome inhibitor. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type II anti-CD20 antibody and a proteasome inhibitor.
